Trial
NCT04237649
KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Novartis Pharmaceuticals
Collaborators
—
Condition
Solid Tumors
Intervention
KAZ954
Why stopped
Business reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-18